首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   530篇
  免费   67篇
  国内免费   2篇
耳鼻咽喉   14篇
儿科学   2篇
妇产科学   11篇
基础医学   54篇
口腔科学   43篇
临床医学   29篇
内科学   49篇
皮肤病学   78篇
神经病学   7篇
特种医学   14篇
外国民族医学   3篇
外科学   66篇
综合类   32篇
预防医学   10篇
眼科学   3篇
药学   38篇
中国医学   2篇
肿瘤学   144篇
  2024年   1篇
  2023年   8篇
  2022年   11篇
  2021年   12篇
  2020年   10篇
  2019年   53篇
  2018年   49篇
  2017年   31篇
  2016年   19篇
  2015年   19篇
  2014年   53篇
  2013年   35篇
  2012年   26篇
  2011年   43篇
  2010年   27篇
  2009年   25篇
  2008年   19篇
  2007年   26篇
  2006年   23篇
  2005年   15篇
  2004年   12篇
  2003年   20篇
  2002年   14篇
  2001年   6篇
  2000年   11篇
  1999年   5篇
  1998年   5篇
  1997年   2篇
  1996年   3篇
  1994年   1篇
  1993年   2篇
  1992年   2篇
  1991年   1篇
  1990年   2篇
  1989年   1篇
  1987年   1篇
  1986年   1篇
  1985年   2篇
  1984年   1篇
  1981年   2篇
排序方式: 共有599条查询结果,搜索用时 15 毫秒
81.

Background and purpose

To compare cosmesis and local recurrence (LR) of definitive external beam radiation therapy (EBRT) vs brachytherapy (BT) for indolent basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin.

Materials and methods

Studies including patients with T1-2?N0 SCCs/BCCs treated with definitive EBRT/BT and ≥10?months follow-up were analyzed. The primary endpoint was post-treatment cosmesis, categorized as “good,” “fair,” or “poor.” The secondary endpoint was LR. Mixed effects regression models were used to estimate weighted linear relationships between biologically equivalent doses with α/β?=?3 (BED3) and cosmetic outcomes.

Results

A total of 9965 patients received EBRT and 553 received BT across 24 studies. Mean age was 73?years, median follow-up was 36?months, and median dose was 45?Gy/10 fractions at 4.4?Gy/fraction. At BED3 of 100?Gy, “good” cosmesis was more frequently observed in patients receiving BT, 95% (95% CI: 88–100%) vs 79% (95% CI: 60–82%), p?<?0.05. Similar results were found for “good” cosmesis at BED3 >100?Gy. No difference in “poor” cosmesis was noted at any BED3. LR was?<7% for both at one year.

Conclusion

BT has favorable cosmesis over EBRT for skin SCCs/BCCs at common fractionation regimens. Prospective studies comparing EBRT vs BT are warranted.  相似文献   
82.
Background: Lung cancer is one of the most common cancers in the world and a major cause of death from cancer. One of the important indicators to compare the prevalence and incidence of the disease is a change in the trend. The aim of this study was to investigate the changes in the incidence of lung cancer in Iran. Materials and Methods: This study was conducted based on existing data obtained from a national registry of cancer cases and the Disease Management Center of Ministry of Health in Iran. All cases registered in the country were included during 2003-2008. Incidence rates were reported based on the direct method and standard population of World Health Organization. The study also examined the morphology of common lung cancers. Trends in incidence underwent joinpoint regression analysis. Results: Based on the results of this study, 14,403 cases of lung cancer have been recorded of which 10,582 cases were in men and 3,821 in women. Highest incidence rates were observed in the 80-84 age group. Considerable variation across provinces was evident. In females squamous cell carcinoma (SCC) demonstrated a reduction from 24% to 16% of lesions over the period of study, while adenocarcinoma rose from 21% to 29%. In males a similar reduction in SCC was apparent (42% to 29%, again with increase in AC (13 % to 18%). Conclusions: The results show that the increase in the incidence of lung cancer the trend is that more men than women and in men and may be caused by changes in smoking pattern. The incidence of lung cancer in the North West and West provinces was higher than in other regions.  相似文献   
83.
ECRG1 (esophageal cancer related gene 1) is a novel candidate member of the tumor suppressor gene familypreviously found to be down regulated in human esophageal cancer (ESCC). So far no evidence regarding therole of the ECRG1 gene in this cancer has been reported from the Kashmir valley, located on the border of thehigh risk ‘esophageal cancer belt’. A case control study was therefore carried out with genomic DNA from 165newly diagnosed ESCC patients (cases) and 200 control subjects. DNA was analyzed for ECRG1 polymorphismsby RFLP PCR, gel electrophoresis and direct sequencing. A statistically significantly increased risk of ESCCwas found to be associated with the ECRG1 Arg/Gln and Gln/Gln genotype occurrence compared to the Arg/Arg genotype (odds ratio (OR) 1.698, 95% confidence interval (CI) 1.112–2.593); P= 0.0138) was observed.Statistically significant results were also obtained between the ECRG1 polymorphism and histophathologicalgrade, smoking, dysphagia, low fruit/vegetable intake and salt tea consumption.  相似文献   
84.
目的 了解正常口腔黏膜,癌前病变及癌组织中内皮素I(ET-I)表达特点及其变化规律。方法采用免疫组化和图象分析技术,对人正常口腔黏膜(NOR)10例、口腔黏膜下纤维化(OSF)10例、鳞状细胞癌(SCC)15例上皮细胞的ET-I含量进行图像分析。结果 ①ET-I在OSF、OLK、SCC组织中的表达增强,阳性物质主要位于上皮棘细胞、基质细胞的胞浆胞膜上,且ET-I含量显著高于正常对照组(p<0.01)。②OLK、SCC上皮细胞ET-I含量呈显著增加趋势(p<0.05)。③OSF上皮细胞ET-I含量显著高于OLK(p<0.05),与SCC相比无显著性差异(p>0.05)。结论 ET-I含量在口腔癌前病变至癌变过程中可能存在一种量变关系,OSF中ET-I过量表达可能提示其上皮细胞的癌变潜能。  相似文献   
85.
86.
87.
88.
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号